icon-folder.gif   Conference Reports for NATAP  
 
  EASL - The International Liver Congress 2014
49th Annual Meeting of the European
Association for the Study of the Liver
London, United Kingdom  April 9-13
Back grey_arrow_rt.gif
 
 
 
Resistance Analysis of HCV Genotype 1 Patients Treated With Sofosbuvir in Combination With Ledipasvir or the NS5B Non-Nucleoside Inhibitor GS-9669: The ELECTRON Study
 
 
  Reported by Jules Levin
EASL 2014 April 9-13 London, UK
 
Evguenia Svarovskaia,1 Ross Martin,1 Viktoria Gontcharova,1 Robert H. Hyland,1 Edward J. Gane,2 Catherine A. Stedman,3 William T. Symonds,1 Michael D. Miller,1 Hongmei Mo1
1Gilead Sciences, Inc., Foster City, California, USA; 2Auckland City Hospital, Grafton, Auckland, New Zealand; 3Christchurch Hospital and University of Otago, Christchurch, New Zealand

EASL1.gif

EASL2.gif

EASL3.gif

EASL4.gif

EASL5.gif

EASL6.gif

EASL7.gif

EASL8.gif